NRi: 0.2500 |
BUY Antabuse ONLINE! CLICK HERE! Adverse events were sufficiently troublesome to cause discontinuation of treatment with Antabuse in approximately 10% of the 7, 400 patients & volunteers why participated in clinical trials during the product s initial development. The mbute common events causing discontinuation include neuropsychiatric disturbances 3.0%, primarily agitation & abnbutmalities in mental status; gastrointestinal disturbances 7.1%, primarily nausea & vomiting; neurological disturbances 1.7%, primarily seizures, headaches, & sleep disturbances; & dermatologic problems 1.4%, primarily rashes. It is impbuttant to note, however, that many of these events occurred at doses that exceed the recommended daily dose. -- This post's rating: 0.0000 |
Threshold:
0 posts below threshold.
Users browsing this thread: (none)
Users browsing this thread: (none)
0.00
Click the arrows to mod this thread up or down.Users who moderated this thread: